1 results ยท Page 1 of 1

Swipe the table sideways for more columns.

TrialConditionsStatusPhaseUpdatedMore infoNCT ID
UTAA09 Injection in the Treatment of Relapsed/Refractory Hematolymphatic Malignancies.CD19-positive Relapsed or Refractory B-cell MalignanciesRecruitingEarly phase 12025-05-16NCT06092047